Multicenter retrospective study of thrombolytic therapy including AT-III for portal vein thrombosis
Not Applicable
- Conditions
- portal vein thrombus
- Registration Number
- JPRN-UMIN000044249
- Lead Sponsor
- Department of Gastroenterology, Nippon Medecial School
- Brief Summary
This study suggests that maintenance therapy, favorable response, and absence of PVT progression may suppress or control liver-related events in antithrombin III-based therapy for patients with PVT. Specifically, maintenance therapy could suppress not only liver-related events, but also PVT progression and improve the prognosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate and elimination rate of thrombolysis
- Secondary Outcome Measures
Name Time Method